Using gene-targeting methods, a progesterone receptor Cre knockin (PR-Cre) mouse was generated in which Cre recombinase was inserted into exon 1 of the PR gene. The insertion positions the Cre gene downstream (and under the specific control) of the endogenous PR promoter. As for heterozygotes for th
Cre-mediated recombination in the skin melanocyte lineage
✍ Scribed by Véronique Delmas; Silvia Martinozzi; Yveline Bourgeois; Martin Holzenberger; Lionel Larue
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 386 KB
- Volume
- 36
- Category
- Article
- ISSN
- 1526-954X
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Summary: Organ‐specific expression of a Cre recombinase allows the analysis of gene function in a particular tissue or cell type. Using a 6.1 kb promoter from the mouse tyrosinase gene, we generated and characterized two lines of transgenic mice that express Cre recombinase in melanoblasts. Utilizing a Cre‐responsive reporter mouse strain, genetic recombination was detected in the melanoblasts of the skin from embryonic day 11.5. In addition, Cre‐expression was detected in the skin and eyes of mice. Cre transgene activity was occasionally detected in the brain and peripheral nerves but not in other tissues. When Tyr::Cre mice were crossed with mice carrying a homozygous loxP conditional mutation for the insulin‐like growth factor receptor gene (Igf1r), Cre‐melanoblast‐specific recombination pattern was confirmed and no abnormal phenotype was observed. In conclusion, Tyr::Cre transgenic mice provide a valuable tool to follow the cell lineage and to examine gene function in melanocyte development and transformation. genesis 36:73–80, 2003. © 2003 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract We generated two complementary systems for Cre‐mediated recombination of target genes in the mouse digestive epithelium and tested them with a Cre‐reporter mouse strain. Cre was expressed under the control of a 9 kb regulatory region of the murine villin gene (vil‐Cre). Genetic recombin